Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
Kura Oncology to Report Third Quarter 2023 Financial Results
04:05pm, Thursday, 26'th Oct 2023
SAN DIEGO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment
What Makes Kura Oncology (KURA) a New Buy Stock
01:31pm, Wednesday, 04'th Oct 2023
Kura Oncology (KURA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Kura's Ziftomenib: The Swiss Army Knife In AML Therapy
04:40am, Monday, 25'th Sep 2023
Kura Oncology's lead candidate, ziftomenib, shows dual-functionality in treating NPM1-mutant AML and overcoming resistance mutations. Company's financials robust with $477M in liquid assets, offsettin
Kura Oncology, Inc. (KURA) Q2 2023 Earnings Call Transcript
10:41am, Sunday, 06'th Aug 2023
Kura Oncology, Inc. (NASDAQ:KURA ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Pete De Spain - Senior Vice President, Investor Relations & Corporate Communications
7 Best Cancer Stocks to Invest in Now
07:00am, Friday, 28'th Jul 2023
One of the most aggressive and difficult-to-treat ailments, cancer is a disease that involves the uncontrolled division and growth of malignant cells. There are many types of cancer, many of which hav
Kura Oncology to Report Second Quarter 2023 Financial Results
07:30am, Thursday, 27'th Jul 2023
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment
Kura Oncology: Targeted AML Therapy Continues To Deliver
04:23pm, Wednesday, 12'th Jul 2023
Kura Oncology, Inc. has additional updated results released from the KOMET-001 study, as part of an oral late-breaker presentation shown on June 11, 2023 at the EHA; 35% achieved CR with full count re
Kura Oncology (KURA) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:03am, Tuesday, 11'th Jul 2023
Kura Oncology (KURA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revi
Kura Oncology stock falls more than 5% after company announces share offering
05:49pm, Tuesday, 13'th Jun 2023
Shares of Kura Oncology Inc. KURA, -1.24% dropped nearly 6% in the aftermarket Tuesday after the biotech said it plans to sell $100 million worth of shares, plus an option for underwriters to buy addi
Kura Oncology to Participate in Two Upcoming Investor Conferences
07:30am, Tuesday, 23'rd May 2023
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment o
Kura Oncology, Inc. (KURA) Q1 2023 Earnings Call Transcript
10:13pm, Wednesday, 10'th May 2023
Kura Oncology, Inc. (NASDAQ:KURA ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Pete De Spain - SVP, IR & Corporate Communications Troy Wilson - Chairman, CEO & Presid
Kura Oncology to Report First Quarter 2023 Financial Results
07:30am, Wednesday, 03'rd May 2023
SAN DIEGO, May 03, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment o
3 Under-the-Radar Stocks That AI Predicts Will Soar in May
02:07pm, Monday, 01'st May 2023
Investors looking for help finding the best under-the-radar stocks may have a new ally: the AI chatbot. Using the prompt “publicly traded companies that may be on the cusp of breaking out in popula
Kura Oncology to Participate in Upcoming Investor Conferences
07:30am, Wednesday, 01'st Mar 2023
SAN DIEGO, March 01, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment
Kura Oncology, Inc. (KURA) Q4 2022 Earnings Call Transcript
10:11pm, Thursday, 23'rd Feb 2023
Kura Oncology, Inc. (NASDAQ:KURA ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Pete De Spain - Senior Vice President of Investor Relations and Corporate Communic
